Lexiang Cheng - Search Results

Year	Number of Results
2003	4
2004	2
2005	1
2006	6
2007	7
2008	2
2009	5
2010	3
2011	2
2012	2
2013	2
2015	1
2016	1
2017	2
2018	3
2019	5
2020	8
2021	4
2022	4
2023	4
2024	1

1

Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.

Ji GW, Zhu FP, Xu Q, Wang K, Wu MY, Tang WW, Li XC, Wang XH. Ji GW, et al. Among authors: li xc. Radiology. 2020 Mar;294(3):568-579. doi: 10.1148/radiol.2020191470. Epub 2020 Jan 14. Radiology. 2020. PMID: 31934830

2

Apolipoprotein A-1 protected hepatic ischaemia-reperfusion injury through suppressing macrophage pyroptosis via TLR4-NF-κB pathway.

Chen RX, Jiang WJ, Liu SC, Wang ZY, Wang ZB, Zhou T, Chen YA, Wang JF, Chang J, Wang YR, Zhang YD, Wang XH, Li XC, Li CX. Chen RX, et al. Among authors: li xc. Liver Int. 2023 Jan;43(1):234-248. doi: 10.1111/liv.15448. Epub 2022 Oct 24. Liver Int. 2023. PMID: 36203339

3

Apolipoprotein A-1 Accelerated Liver Regeneration Through Regulating Autophagy Via AMPK-ULK1 Pathway.

Wang ZY, Chen RX, Wang JF, Liu SC, Xu X, Zhou T, Chen YAL, Zhang YD, Li XC, Li CX. Wang ZY, et al. Among authors: li xc. Cell Mol Gastroenterol Hepatol. 2024;17(4):539-551. doi: 10.1016/j.jcmgh.2023.12.004. Epub 2023 Dec 18. Cell Mol Gastroenterol Hepatol. 2024. PMID: 38122985 Free PMC article.

4

Translating imaging traits of mass-forming intrahepatic cholangiocarcinoma into the clinic: From prognostic to therapeutic insights.

Ji GW, Xu Q, Jiao CY, Lu M, Xu ZG, Zhang B, Yang Y, Wang K, Li XC, Wang XH. Ji GW, et al. Among authors: li xc. JHEP Rep. 2023 Jul 4;5(10):100839. doi: 10.1016/j.jhepr.2023.100839. eCollection 2023 Oct. JHEP Rep. 2023. PMID: 37663120 Free PMC article.

5

Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer.

Seesaha PK, Wang KX, Wang GQ, Cui TY, Zhao FJ, Pan LL, Li XC, Shu YQ, Chen XF. Seesaha PK, et al. Among authors: li xc. Onco Targets Ther. 2021 Mar 12;14:1873-1882. doi: 10.2147/OTT.S269671. eCollection 2021. Onco Targets Ther. 2021. PMID: 33737812 Free PMC article. Review.

6

Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study.

Shi GM, Huang XY, Wen TF, Song TQ, Kuang M, Mou HB, Bao LQ, Zhao HT, Zhao H, Feng XL, Zhang BX, Peng T, Zhang YB, Li XC, Yu HS, Cao Y, Liu LX, Zhang T, Wang WL, Ran JH, Liu YB, Gong W, Chen MX, Cao L, Luo Y, Wang Y, Zhou H, Yang GH, Fan J, Zhou J. Shi GM, et al. Among authors: li xc. Cancer Med. 2023 Feb;12(4):4137-4146. doi: 10.1002/cam4.5273. Epub 2022 Sep 20. Cancer Med. 2023. PMID: 36127767 Free PMC article. Clinical Trial.

7

BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways.

Jiao CY, Feng QC, Li CX, Wang D, Han S, Zhang YD, Jiang WJ, Chang J, Wang X, Li XC. Jiao CY, et al. Among authors: li xc. Cell Death Dis. 2021 Jan 11;12(1):63. doi: 10.1038/s41419-020-03234-x. Cell Death Dis. 2021. PMID: 33431813 Free PMC article.

8

MiR-30a-5p promotes cholangiocarcinoma cell proliferation through targeting SOCS3.

Zhang JW, Wang X, Li GC, Wang D, Han S, Zhang YD, Luo CH, Wang HW, Jiang WJ, Li CX, Li XC. Zhang JW, et al. Among authors: li xc. J Cancer. 2020 Mar 26;11(12):3604-3614. doi: 10.7150/jca.41437. eCollection 2020. J Cancer. 2020. PMID: 32284757 Free PMC article.

9

CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.

Jiao CY, Zhang H, Ji GW, Xu Q, Lu M, Zhang B, Yang Y, Wang XH, Li XC. Jiao CY, et al. Among authors: li xc. Eur Radiol. 2022 Dec;32(12):8326-8338. doi: 10.1007/s00330-022-08914-0. Epub 2022 Jun 16. Eur Radiol. 2022. PMID: 35708837

10

Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma.

Ji GW, Jiao CY, Xu ZG, Li XC, Wang K, Wang XH. Ji GW, et al. Among authors: li xc. BMC Cancer. 2022 Mar 11;22(1):258. doi: 10.1186/s12885-022-09352-3. BMC Cancer. 2022. PMID: 35277130 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

62 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year